Skip to Content
Contact Form Map & Directions Videos

Search Results: yaz

Dangerous Drugs — Why can’t testing be done BEFORE profits?

09/27/2011
Blog
BY

Your blood needs to clot, but it is a delicate balance. Insufficient clotting leads to excessive bleeding and too much clotting leads to obstructed blood flow, pulmonary embolism and strokes. So, it is understandable that the Food & Drug Administration became worried about reports that birth control medications containing drospirenone […]

Read More

Unsuspecting Young Women and the Yaz Secret

06/3/2011
Blog
BY

Is it possible that four studies have demonstrated that certain birth control medications, like Yaz, Yasmin, and Ocella, are dangerous and the manufacturer, Bayer, knew nothing about the dangers? It is reasonable to conclude that if the manufacturer did not actually know, through reasonable and prudent drug evaluation; those dangerous […]

Read More

Yaz, Yasmin and Ocella — New Studies Confirm Old Concerns

05/31/2011
Blog
BY

According to new studies, the latest generation of birth control pills, including Yaz, Yasmin, and Ocella, put women at a higher risk of blood clots than other types of birth control pills.  These fourth-generation birth control pills carry a two-to-three times greater risk of venous thrombosis, also known as blood […]

Read More

What was Bayer thinking with "all that Yaz"?

04/25/2011
Blog
BY

What was Bayer thinking when they came out with the birth control pill Yaz? Based on another study, this one published in the British Medical Journal, demonstrates that the key ingredient in Yaz (also in Yasmin and Ocella) causes a six times increase for the incidence of clots in users. […]

Read More

Zicam Litigation Heats Up

04/9/2010
Blog
BY

Multidistrict litigation proceedings against Matrixx Initiatives, Inc., the manufacturer of the over-the-counter cold product Zicam, are heating up. This is a process known as multidistrict litigation (or an MDL) and is often utilized in mass tort cases where a number of claimants have been injured in a similar fashion by […]

Read More

Drug Marketing Direct to Consumers

01/13/2010
Blog
BY

The Food & Drug Administration has recently notified Eli Lilly & Co. and Bayer Healthcare that it has objections to ads used for some of their drugs. For Eli Lilly, it was print advertisements for its depression drug, Cymbalta. Print ads used on WebMD Little Blue Book; a publication to […]

Read More

Yaz Litigation in Mass Tort Coordination

10/7/2009
Blog
BY

The United States Judicial Panel on Multidistrict Litigation issued its order on October 1, 2009, establishing MDL No. 2100 for individual lawsuits filed by women who have been injured or died as a result of their ingestion of Yasmin and Yaz oral contraceptive products.  All of the cases pending in […]

Read More

National Coordination of YAZ Litigation Requested

09/29/2009
Blog
BY

On September 24, 2009, a hearing was held in Richmond, Virginia before the National Panel on Multi-District Litigation with regard the lawsuits that have been filed against the manufacturers of YAZ, Yasmin and Ocella.  This Panel of federal judges who oversee the establishment and coordination of mass torts litigation within […]

Read More

The Show Must Go On and all that Yaz!

08/5/2009
Blog
BY

There are certain drug compounds that I, as a consumer, can not purchase without the permission (think prescription here) of a licensed physician. There is very good reason for this. There are drugs for which the use must be weighed and evaluated by trained medical people. In some cases the […]

Read More

Hear What Our Clients Have To Say

"Nick DeBellis obtained the maximum recovery of full insurance limits in the case we worked on. He is a true professional and recommend him to anyone in South Florida."
Posted By: Michael Geoffroy